Cimavax-EGF in Combination with First-Line Chemotherapy in III Stage NSCLC

被引:0
|
作者
Neninger, E. [1 ]
Caceres, H. [1 ]
Camacho, K. [2 ]
Hernandez, M. [3 ]
Santiesteban, E. [2 ]
Del Castillo, C. [4 ]
Menendez, Y. [4 ]
Gonzalez, B. [5 ]
机构
[1] Hermanos Ameijeiras Hosp, Clin Oncol, Havana, Cuba
[2] Jose Ramon Lopez Hosp, Clin Oncol, Matanzas, Cuba
[3] Mol Immunol Ctr, Havana, Cuba
[4] Hermanos Ameijeiras Hosp, Radiotherapy, Havana, Cuba
[5] Ramon Lopez Tabranes Hosp, Matanzas, Cuba
关键词
Cimavax Egf vaccine; IIIa NSCLC; immunogenicity;
D O I
10.1016/j.jtho.2019.08.1435
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
P2.01-92
引用
收藏
页码:S676 / S677
页数:2
相关论文
共 50 条
  • [1] Vaxira and CIMAvax-EGF Therapeutic Vaccines Combination in the Advanced NSCLC Treatment
    Macias, Amparo E.
    Ortiz, Ramon
    Santiesteban, Eduardo
    Popa, Xitlally
    Zayas, Anet
    Mazorra, Zaima
    Mendoza, Ivis
    Garcia, Elena
    Gomez, Roberto
    Crombet, Tania
    JOURNAL OF THORACIC ONCOLOGY, 2016, 11 (10) : S236 - S237
  • [2] CIMAvax-EGF: Toward long-term survival of advanced NSCLC
    Crombet, T.
    Saavedra, D.
    Neninger, E.
    Rodriguez, C.
    Viada, C.
    Mazorra, Z.
    Dy, G.
    Lee, K.
    Groman, A.
    Lage, A.
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2019, 49 : 1646 - 1647
  • [3] CIMAvax-EGF: Toward long-term survival of advanced NSCLC
    Saavedra, Danay
    Neninger, Elia
    Rodriguez, Camilo
    Viada, Carmen
    Mazorra, Zaima
    Lage, Agustin
    Crombet, Tania
    SEMINARS IN ONCOLOGY, 2018, 45 (1-2) : 34 - 40
  • [4] Augmenting antibody response to EGF-depleting immunotherapy: Findings from a phase I trial of CIMAvax-EGF in combination with nivolumab in advanced stage NSCLC
    Evans, Rachel
    Lee, Kelvin
    Wallace, Paul K.
    Reid, Mary
    Muhitch, Jason
    Dozier, Askia
    Mesa, Circe
    Luaces, Patricia L.
    Santos-Morales, Orestes
    Groman, Adrienne
    Cedeno, Carlos
    Cinquino, Aileen
    Fisher, Daniel T.
    Puzanov, Igor
    Opyrchal, Mateusz
    Fountzilas, Christos
    Dai, Tong
    Ernstoff, Marc
    Attwood, Kristopher
    Hutson, Alan
    Johnson, Candace
    Mazorra, Zaima
    Saavedra, Danay
    Leon, Kalet
    Lage, Agustin
    Crombet, Tania
    Dy, Grace K.
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [5] Interim Results from a Phase I/II Trial of Nivolumab in Combination with CIMAvax-EGF as Second-Line Therapy in Advanced NSCLC
    Dy, G.
    Dozier, A.
    Reid, M.
    Lee, K.
    Miller, A.
    Wallace, P.
    Puzanov, I.
    Opyrchal, M.
    Ernstoff, M.
    Johnson, C.
    Mazorra, Z.
    Saavedra, D.
    Leon, K.
    Lage, A.
    Crombet, T.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S740 - S740
  • [6] High Basal Serum EGF Levels Predicts Response to CIMAvax-EGF, a Therapeutic Vaccine for Advanced NSCLC
    Santos Morales, O.
    Luaces, P.
    Crombet, T.
    Rodriguez, C.
    Neninger, E.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S495 - S495
  • [7] Survival of NSCLC Patients Treated with Cimavax-EGF as Switch Maintenance in the Real-World Scenario
    Vega, Yoanna I. Flores
    Gonzalez, Diana L. Paramo
    Sarmiento, Sofia C. Alsina
    Tul, Luis E. Alsina
    Valdes, Iris B. Inguanzo
    Machado, Jorge Rodriguez
    Larrinaga, angel Elejalde
    Rodriguez, Justo E. Flores
    Garcia, Janet Lamadrid
    Otero, Danay Corrales
    Toirac, Ramon Ropero
    Ramos, Tania Crombet
    Medina, Elias A. Gracia
    JOURNAL OF CANCER, 2023, 14 (05): : 874 - 879
  • [8] Effectiveness of docetaxel and cisplatin combination as first-line chemotherapy in advanced NSCLC
    Behera, D
    Aggarwal, A
    Gupta, D
    Jindal, S
    Aggarwal, R
    Sharma, S
    Kapoor, R
    LUNG CANCER, 2005, 49 : S389 - S389
  • [9] First-line immune-chemotherapy combination for squamous NSCLC is already a reality
    Hendriks, Lizza E. L.
    Menis, Jessica
    Remon, Jordi
    TRANSLATIONAL LUNG CANCER RESEARCH, 2020, 9 (03) : 819 - 823
  • [10] Avelumab in Combination With Cetuximab and Chemotherapy as First-Line Treatment for Patients With Advanced Squamous NSCLC
    Andric, Zoran
    Galffy, Gabriella
    Dols, Manuel Cobo
    Szima, Barna
    Stojanovic, Goran
    Petrovic, Marina
    Felip, Enriqueta
    Baz, David Vicente
    Aix, Santiago Ponce
    Juan-Vidal, Oscar
    Szalai, Zsuzsanna
    Losonczy, Gyorgy
    Blanco, Antonio Calles
    Bernabe, Reyes
    Ledo, Gema Garcia
    Hernandez, Andres Aguilar
    Duecker, Klaus
    Zhou, Dongli
    Schroeder, Andreas
    Guezel, Guelseren
    Ciardiello, Fortunato
    JTO CLINICAL AND RESEARCH REPORTS, 2023, 4 (02):